19
1
49
2
2
18
1b
1d
18
32
63
1d
2 29
1d
25
Daniel S. Lefler, MD
88
63
Assistant Professor of Clinical Medicine (Hematology-Oncology)
28
ac
3
5f
Assistant Program Director of the Hematology/Oncology Fellowship Program, Hospital of the University of Pennsylvania
87
Associate Clinical Director of Sarcoma Medical Oncology, Abramson Cancer Center
4f
Medical Director, PCAM 3
11
Department: Medicine
4
1
b
1d
46
Contact information
54
4
3
3
3
2
4
b
1f
54
Perelman Center for Advanced Medicine
1f 3400 Civic Center Blvd
38 10-145 South Pavilion
Philadelphia, PA 19104
26
1f 3400 Civic Center Blvd
38 10-145 South Pavilion
Philadelphia, PA 19104
35
a9
12
13
Education:
21 7 BS 36 (Neuroscience (Minor in Religious Studies)) c
36 The College of William & Mary, 2012.
21 7 MD 16 (Medicine ) c
43 Cooper Medical School of Rowan University , 2016.
c
3
3
3
3
8d
Permanent link21 7 BS 36 (Neuroscience (Minor in Religious Studies)) c
36 The College of William & Mary, 2012.
21 7 MD 16 (Medicine ) c
43 Cooper Medical School of Rowan University , 2016.
c
2 29
21
1e
1d
24
2b
29
27
23
14d Mohammad S Farooq, Neha Shafique, Gracia M Vargas, Jennifer Guo, John T Miura, Daniel S Lefler, Giorgos C Karakousis: Neoadjuvant Immunotherapy for Resectable Dedifferentiated Liposarcoma: A National Cohort Analysis. J Surg Oncol 131(8): 1683-1691. June 2025.
188 Gabriel Aleixo, Lee Hartner, Mark Diamond, Lazlo Nziga, Daniel Lefler: Liposomal vs conventional doxorubicin as first-line therapy in advanced soft tissue sarcomas: A tertiary US center’s 8.5-year experience. The American Society of Clinical Oncology Annual Meeting, Chicago, IL. May 2025 Notes: "Poster Presentation"
193 Lefler, D.S., Maki, R.G., Somaiah, N.,…Basu Mallick, A.: Characterizing the genomic landscape of perivascular epithelioid cell family of tumors in a real-world patient population using the Foundation Medicine genomic database. Connective Tissue Oncology Society Annual Meeting, San Diego, CA. Nov 2024 Notes: "Oral presentation"
139 Lefler, D.S., Moding, E.J., Basu Mallick, A: mTOR activity: a biomarker for chemo- and immunotherapy response and outcomes in sarcomas. Connective Tissue Oncology Society Annual Meeting, San Diego, CA. Nov 2024 Notes: "Poster Presentation"
17a Lefler, D.S., Elliott, A., Blomain, E.S.,…Basu Mallick, A: Characterizing patterns of mTORC1 activation across sarcomas using single-sample gene set enrichment analysis (ssGSEA) and a national biomarker database. American Society of Clinical Oncology Annual Meeting, Chicago,IL June 2024 Notes: "Poster"
11a Jirka GW, Lefler DS, Russo J, Bashir B.: Colon adenocarcinoma and Birt-Hogg-Dubé syndrome in a young patient: case report and exploration of pathologic implications. Cancer Biol Ther 24(1): 2184153, Dec 2023.
111 Lefler DS, Manobianco SA, Bashir B.: Immunotherapy resistance in solid tumors: mechanisms and potential solutions. Cancer Biol Ther 25(1): 2315655, Dec 2023 Notes: doi: 10.1080/15384047.2024.2315655.
152 Robbins J, Halegoua-DeMarzio D, Basu Mallick A, Vijayvergia N, Ganetzky R, Lavu H, Giri VN, Miller J, Maley W, Shah AP, DiMeglio M, Ambelil M, Yu R, Sato T, Lefler DS: Liver Transplantation in a Woman with Mahvash Disease. N Engl J Med 389(21): 1972-1978, Nov 2023.
134 Lefler, D.S., Elliott, A., Maki, R.G.,…Basu Mallick, A.: Overexpression of cyclin dependent kinases and cyclins across sarcomas beyond CDK4. Connective Tissue Oncology Society Annual Meeting, Dublin, Ireland Nov 2023 Notes: "Poster"
2c
7
1d
1f
Selected Publications
21b Daniel S Lefler, Andrew Elliott, Wei Jiang, Ubaldo Martinez-Outschoorn, Jude Al-Sabah, Daniel M Freed, Caitlin M King, Robert G Maki, Richard F Riedel, Jaime F Modiano, Daniel Hübschmann, Hanno Glimm, Stefan Fröhling, Matthew Oberley, Sosipatros A Boikos, Atrayee Basu Mallick: Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma. JCO Precis Oncol 9: e2500149. July 2025.14d Mohammad S Farooq, Neha Shafique, Gracia M Vargas, Jennifer Guo, John T Miura, Daniel S Lefler, Giorgos C Karakousis: Neoadjuvant Immunotherapy for Resectable Dedifferentiated Liposarcoma: A National Cohort Analysis. J Surg Oncol 131(8): 1683-1691. June 2025.
188 Gabriel Aleixo, Lee Hartner, Mark Diamond, Lazlo Nziga, Daniel Lefler: Liposomal vs conventional doxorubicin as first-line therapy in advanced soft tissue sarcomas: A tertiary US center’s 8.5-year experience. The American Society of Clinical Oncology Annual Meeting, Chicago, IL. May 2025 Notes: "Poster Presentation"
193 Lefler, D.S., Maki, R.G., Somaiah, N.,…Basu Mallick, A.: Characterizing the genomic landscape of perivascular epithelioid cell family of tumors in a real-world patient population using the Foundation Medicine genomic database. Connective Tissue Oncology Society Annual Meeting, San Diego, CA. Nov 2024 Notes: "Oral presentation"
139 Lefler, D.S., Moding, E.J., Basu Mallick, A: mTOR activity: a biomarker for chemo- and immunotherapy response and outcomes in sarcomas. Connective Tissue Oncology Society Annual Meeting, San Diego, CA. Nov 2024 Notes: "Poster Presentation"
17a Lefler, D.S., Elliott, A., Blomain, E.S.,…Basu Mallick, A: Characterizing patterns of mTORC1 activation across sarcomas using single-sample gene set enrichment analysis (ssGSEA) and a national biomarker database. American Society of Clinical Oncology Annual Meeting, Chicago,IL June 2024 Notes: "Poster"
11a Jirka GW, Lefler DS, Russo J, Bashir B.: Colon adenocarcinoma and Birt-Hogg-Dubé syndrome in a young patient: case report and exploration of pathologic implications. Cancer Biol Ther 24(1): 2184153, Dec 2023.
111 Lefler DS, Manobianco SA, Bashir B.: Immunotherapy resistance in solid tumors: mechanisms and potential solutions. Cancer Biol Ther 25(1): 2315655, Dec 2023 Notes: doi: 10.1080/15384047.2024.2315655.
152 Robbins J, Halegoua-DeMarzio D, Basu Mallick A, Vijayvergia N, Ganetzky R, Lavu H, Giri VN, Miller J, Maley W, Shah AP, DiMeglio M, Ambelil M, Yu R, Sato T, Lefler DS: Liver Transplantation in a Woman with Mahvash Disease. N Engl J Med 389(21): 1972-1978, Nov 2023.
134 Lefler, D.S., Elliott, A., Maki, R.G.,…Basu Mallick, A.: Overexpression of cyclin dependent kinases and cyclins across sarcomas beyond CDK4. Connective Tissue Oncology Society Annual Meeting, Dublin, Ireland Nov 2023 Notes: "Poster"
2c